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lnositol !,4,5trisphosphate (Ins (1,4,5)P,)-stimulated Caz+ release is inhibited by low concentrations of heparin 
(IC,, =4.5 pg/ml). GTP-stimulated Ca*+ release is unaffected at a heparin concentration of 16 fig/ml. Addition of heparin 
after Ins (1,4,5)P, causes the rapid re-uptake of Ins (1,4,5)P,-releasable Ca*+. 
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1. INTRODUCTION 
Upon stimulation of plasma membrane-bound 
receptors, the phospholipase C-catalysed hydro- 
lysis of phosphatidylinositol 4,5-bisphosphate 
(PtdIns (4,5)P2) results in the production of Ins 
(1,4,5)P3 and diacylglycerol (reviews [ 1,2]). Ins 
(1,4,5)Ps has been shown to be effective at mobilis- 
ing Ca2+ from rat liver microsomal fractions 
(microsomes) [3], this release being greatly in- 
creased if GTP together with 5% poly(ethylene 
glycol) is present in the medium [4-61. It has been 
proposed, from work in our laboratory, that GTP 
brings about its effect by causing the fusion of the 
microsomal vesicles into larger structures [4-61. As 
well as promoting Ins (1,4,5)P~-dependent Ca2+ 
release, GTP itself causes Ca2+ release from micro- 
somes. However, there is mounting evidence that 
the Ins (1,4,5)P3_stimulated efflux and GTP- 
stimulated Ca2+ release from endoplasmic reti- 
culum occur by different mechanisms [7-111. 
It has previously been shown that the sulphated 
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polysaccharide, heparin, can compete with Ins 
(1 ,4,5)P3 for its specific binding site (121. We have 
investigated the effect of heparin on the Ins 
(1,4,5)P3- and GTP-stimulated Ca2+ release from 
rat liver microsomes. It was found that heparin at 
micromolar concentrations strongly inhibited the 
Ins (1,4,5)P3-promoted Ca2+ release whilst no ef- 
fect was observed on the Ca2+ release promoted by 
GTP. 
2. MATERIALS AND METHODS 
Ca*‘-sensitive electrode membranes containing the neutral 
ionophore ETHlOOl were prepared as described by Clapper and 
Lee [13]. Ins (1,4,5)Ps was a kind gift from Dr R.F. Irvine 
(AFRC, Babraham, Cambridge, England). Heparin (sodium 
salt, grade l), phosphocreatine, and creatine kinase were pur- 
chased from Sigma (England). ATP, GTP and DTT were from 
BCL (Lewes, Sussex). 
The microsomal fraction sedimenting at 35 000 x g for 20 min 
was prepared from the livers of fed 250 g male rats as described 
by Dawson and Irvine [3]. Protein was determined by the 
method of Lowry et al. [15], using bovine serum albumin as 
standard. 
Ca*+ uptake and release were routinely measured with a 
Ca’+-sensitive electrode as described [6] with the exception that 
oligomycin and ruthenium red were omitted from the assay 
medium [16]. The assay medium consisted of 150 mM sucrose, 
50 mM KCl, 10 mM Hepes-KOH, pH 7.0, 5% (w/v) PEG, 1 
mM DTT, 2 mM MgClr, 5 mM ATP, 36 ag/ml creatine kinase 
and 5 mM phosphocreatine in a volume of 2.45 ml. Ex- 
periments were carried out at 30°C. 
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3. RESULTS AND DISCUSSION 
The lack of effect that heparin has on the GTP- 
induced Ca*+ release is shown in fig. la (incubation 
medium as described in section 2). This shows that 
addition of 16 pg/ml of heparin has no effect on 
the rate or extent of Ca*+ release when added dur- 
ing the phase of Ca*+ release following GTP addi- 
tion. It was also found that if heparin was present 
in the incubation mixture before the addition of 
microsomes, the time course of Ca*+ uptake and 
that of GTP-stimulated Ca*+ efflux were identical 
to those observed in the absence of heparin (not 
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Fig.]. Effect of heparin on the GTP-stimulated and Ins 
(1,4,5)Pjstimulated Ca’+ release. (a). Heparin (H) (16 pg/ml) 
was added during GTP-stimulated release. Arrows indicate the 
addition of microsomes (3.5 mg protein), M; GTP (~O,LLM), G; 
Ins (1,4,5)Pj (1 pM), I. Dashed line indicates a typical trace in 
the absence of heparin. The trace is slightly displaced 
downwards to ease clarification. (b) Heparin (at the 
concentrations shown) was added when the new steady state of 
Ca2+ loading had been reached after the addition of GTP. Ins 
(1,4,5)P3 (1 PM) was added as shown by the arrow. The trace 
shows only the Ins (1,4,5)P,-stimulated Ca’+ release, however 
the whole trace is similar to that shown in (a), except that 
heparin was added after GTP-dependent Ca’+ release was 
complete. 
shown). Also, we have found that heparin has no 
effect on the GTP-dependent vesicle fusion (not 
shown), as determined by the fluorescence energy 
transfer procedure of Comerford and Dawson 
1161. 
Fig.la,b shows the heparin inhibition of the Ins 
(1,4,5)P3-induced Ca*+ release. In fig. lb, heparin, 
at the indicated concentration, was added after a 
new steady state of free Ca*+ (p&-6.75) had 
been attained after GTP-stimulated Ca*+ release. 
Ins (1,4,5)P~ was added 2 min after heparin. It 
should be noted that occasionally the addition of 
higher concentrations of heparin (i.e. 16 pg/ml) 
resulted in some small amounts of Ca*+ re-uptake 
prior to Ins (1,4,5)P3 addition. This may be due to 
antagonism, by heparin, of some endogenous 
bound Ins (1,4,5)P3, or may indicate a blockade of 
open Ca*+ channels. The data of fig. 1 clearly show 
that heparin acts as a specific antagonist against 
the Ins (1,4,5)P3_stimulated Ca*+ efflux, but has 
no effect on the GTP-stimulated Ca*+ efflux. This 
reinforces the idea that in rat liver microsomes the 
Ins (1,4,5)Pj_stimulated release and GTP-stimul- 
ated Ca*+ efflux occur by different mechanisms. 
Fig.2 is a typical trace showing the effect of 
adding heparin after the Ins (1,4,5)P3-induced 
Ca*+ release has been completed. Heparin addition 
clearly results in the rapid re-uptake of Ca*+ 
previously released by Ins (1,4,5)Ps. This could be 
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Fig.2. Effect of adding heparin after the Ins 
(1,4,5)Pj-stimulated Ca’+ release has ended. Microsomes were 
prepared as described in section 2. GTP (20cM) was present in 
the incubation mixture prior to the addition of microsomes. 
Arrows mark the addition of microsomes (3.0 mg protein), M; 
Ins (1,4,5)P~ (1 PM), I; heparin (at concentrations shown), H. 
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due to displacement of bound Ins (1,4,5)P3 by 
heparin, or to direct blockage of the Ins (1,4,5)P3- 
sensitive Ca2+ channels (see below). The dose- 
response curves for both the inhibition of the Ins 
(1,4,5)P3-induced Ca2+ release and the heparin- 
stimulated Ca2+ re-uptake are shown in fig.3. In 
both cases, a half-maximal effect is obtained at ap- 
prox. 5 fig/ml of heparin. 
Spat and co-workers [14] have shown that the 
rate of dissociation of [32P]Ins (1,4,5)P3 from rat 
liver microsomal binding sites occurs monoex- 
ponentially, with a half-time of approx. 5.9-4.7 
min at 4°C. Our results, however, show that the ef- 
fect of heparin in causing Ca2+ re-uptake is ex- 
tremely rapid. The concentration dependence of 
inhibition of Ca2+ release and stimulated Ca2+ re- 
uptake described here is very similar to that of in- 
hibition of Ins (1,4,5)P3 binding found by Worley 
et al. [12], strongly suggesting that heparin inhibi- 
tion is due to displacement of Ins (1,4,5)P3. Clear- 
ly, the time course of Ca2+ re-uptake shown in 
fig.2 suggests an off-rate for Ins (1,4,5)P3 with a 
time constant of the order of seconds (within the 
time response of the electrode) rather than 
minutes. Therefore, either the off-rate is very 
temperature dependent, or heparin is binding to a 
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Fig.3. Effect of heparin concentration on Ca’+ release and re- 
uptake. The effect of various heparin concentrations on the Ins 
(1,4,5)P,-stimulated Ca’+ release (o), and on the Ca*’ re- 
uptake after the completion of the Ins (1,4,5)Pjstimulated 
Ca*+ release (0) were measured by the techniques shown in 
figs 1 and 2. Each point is the mean of three separate 
experiments carried out on different samples of microsomes. 
binding site distinct from the Ins (1,4,5)P3 site, 
leading to an increased Ins (1,4,5)P3 off-rate. 
The structure of heparin, being a sulphated 
polysaccharide, suggests that it might be acting as 
a structural analogue of Ins (1,4,5)P3, and could 
therefore be binding to the Ins (1,4,5)P3-binding 
site. If this is the case it suggests that the off-rate 
for Ins (1,4,5)P3 leaving the receptor at 
physiological temperature is very much faster than 
would be predicted from the low-temperature data 
of Spat et al. [ 141, but would be very much in line 
with the time response of the termination of the 
Ca2+ signal on removal of the agonists [17]. 
Acknowledgemenfs: The authors would like to thank Derek 
Fulton for excellent technical assistance, Robin Irvine for the 
generous donation of Ins (1,4,5)P3, the SERC for the award of 
a studentship to P.J.C. and the Wellcome Trust for financial 
support to J.G.C. 
REFERENCES 
[l] Berridge, M.J. and Irvine, R.F. (1984) Nature 312, 
315-321. 
[2] Nishizuka, Y. (1984) Nature 308, 693-694. 
[3] Dawson, A.P. and Irvine, R.F. (1984) Biochem. Biophys. 
Res. Commun. 120, 858-864. 
[4] Dawson, A.P. (1985) FEBS Lett. 185, 147-150. 
[5] Dawson, A.P., Comerford, J.G. and Fulton, D.V. (1986) 
Biochem. J. 234, 311-315. 
[6] Dawson, A.P., Hills, G. and Comerford, J.G. (1987) 
Biochem. J. 244, 87-92. 
[7] Henne, V. and Soling, H.D. (1986) FEBS Lett. 202, 
267-273. 
[8] Wolf, B.A., Florholmen, J., Colca, J.R. and McDaniel, 
M.L. (1987) Biochem. J. 242, 137-141. 
[9] Henne, V., Piiper, A. and Soling, H.D. (1987) FEBS Lett. 
218, 153-158. 
[lo] Kiesel, L., Lukacs, G.L., Eberhardt, I., Runnebaum, B. 
and Spat, A. (1987) FEBS Lett. 217, 85-88. 
[ll] Lukacs, G.L., Hajnoczky, G., Hunyady, L. and Spat, A. 
(1987) Biochim. Biophys. Acta 931, 251-254. 
1121 Worley, P.F., Baraban, J.M., Supattapone, S., Wilson, 
V.S. and Snyder, S.H. (1987) J. Biol. Chem. 262, 
12132-12136. 
[13) Clapper, D.L. and Lee, H.C. (1985) J. Biol. Chem. 260, 
13947-13954. 
[14] Spat, A., Fabiato, A. and Rubin, R.P. (1986) Biochem. J. 
233, 929-932. 
[15] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, 
R.J. (1951) J. Biol. Chem. 193, 265-275. 
(161 Comerford, J.G. and Dawson, A.P. (1988) Biochem. J. 
249, 89-93. 
(171 Binet, A., Berthon, B. and Claret, M. (1985) Biochem. J. 
228, 565-574. 
59 
